When I completed my postgraduate studies in the late 1990s, I shelved my doctoral finance thesis in a dusty library. My research had found that corporate governance mechanisms, such as board of ...

Empaveli is a prescription medication used to treat a rare blood disease called paroxysmal nocturnal hemoglobinuria (PNH) and two rare kidney diseases. The following is a brief description of how ...

Already approved to treat four rare diseases, AstraZeneca’s Ultomiris has shown its ability against another rare disorder, IgA nephropathy (IgAN). In a phase 3 trial of adults who are at risk of ...

Neuromyelitis optica spectrum disorder (NMOSD) constitutes a demyelinating condition of the central nervous system driven by autoimmune inflammation. A hallmark of its pathogenesis is the ...

Dozens of new discoveries reveal that defenses evolved by bacteria and viruses billions of years ago still define our own innate immune system. Evolutionary arms races — where one species is pitted ...

At a moment of heightened polarization around diversity, equity, and inclusion (DEI) efforts in the United States and elsewhere—echoing earlier tensions surrounding the #MeToo movement—organizations ...

While there is currently no cure for geographic atrophy, certain treatments, such as complement inhibitors, can help slow its progression by targeting immune system activity that damages the macula.

In this study, investigators evaluated whether a functional C3 gene variant is linked to outcomes after lung transplantation. They focused on the C3R102G polymorphism, which enhances complement ...

Novo Nordisk is paying $240 million for global rights to a Phase 3-ready drug from Omeros that could rival immune disorder medications currently available from companies such as AstraZeneca, Novartis, ...

Please provide your email address to receive an email when new articles are posted on . There were no serious bacterial infections or hospitalizations due to infection over 12 months among adults ...